VACCA, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 39.442
AS - Asia 15.973
EU - Europa 12.121
SA - Sud America 4.274
AF - Africa 752
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 21
Totale 72.619
Nazione #
US - Stati Uniti d'America 38.867
SG - Singapore 6.852
CN - Cina 3.611
BR - Brasile 3.435
IT - Italia 2.177
SE - Svezia 2.177
HK - Hong Kong 2.013
RU - Federazione Russa 1.480
DE - Germania 1.476
FR - Francia 1.034
UA - Ucraina 1.000
FI - Finlandia 969
VN - Vietnam 947
GB - Regno Unito 873
IN - India 522
BD - Bangladesh 330
AR - Argentina 274
CA - Canada 271
IQ - Iraq 216
ID - Indonesia 214
ZA - Sudafrica 191
MX - Messico 172
TR - Turchia 167
CI - Costa d'Avorio 164
JP - Giappone 151
PK - Pakistan 140
BE - Belgio 135
CO - Colombia 134
PL - Polonia 125
NL - Olanda 119
VE - Venezuela 114
IE - Irlanda 110
EC - Ecuador 109
UZ - Uzbekistan 104
SA - Arabia Saudita 101
ES - Italia 99
MA - Marocco 94
PH - Filippine 93
AT - Austria 65
TN - Tunisia 65
CL - Cile 62
CZ - Repubblica Ceca 59
LT - Lituania 55
MY - Malesia 54
JO - Giordania 53
AE - Emirati Arabi Uniti 50
KE - Kenya 48
EG - Egitto 43
PY - Paraguay 39
UY - Uruguay 37
BO - Bolivia 32
KR - Corea 32
NP - Nepal 32
ET - Etiopia 30
IR - Iran 30
PE - Perù 29
AU - Australia 28
AL - Albania 27
JM - Giamaica 27
OM - Oman 27
LB - Libano 26
IL - Israele 25
RS - Serbia 25
AZ - Azerbaigian 23
PS - Palestinian Territory 23
DZ - Algeria 22
KG - Kirghizistan 19
PA - Panama 17
SN - Senegal 17
TH - Thailandia 17
TT - Trinidad e Tobago 16
CH - Svizzera 15
KZ - Kazakistan 15
EU - Europa 14
BH - Bahrain 13
DO - Repubblica Dominicana 12
CR - Costa Rica 11
QA - Qatar 11
RO - Romania 11
BY - Bielorussia 10
HN - Honduras 10
NG - Nigeria 10
TW - Taiwan 10
GR - Grecia 9
PT - Portogallo 9
GE - Georgia 8
KW - Kuwait 8
LY - Libia 8
MK - Macedonia 8
NI - Nicaragua 8
AO - Angola 7
GT - Guatemala 7
AM - Armenia 6
BG - Bulgaria 6
EE - Estonia 6
NO - Norvegia 6
SV - El Salvador 6
BB - Barbados 5
DK - Danimarca 5
MT - Malta 5
Totale 72.473
Città #
Fairfield 4.237
Ashburn 4.055
Singapore 3.743
Chandler 3.323
Woodbridge 3.078
Jacksonville 2.204
Hong Kong 2.000
Houston 1.940
San Jose 1.889
Seattle 1.769
Cambridge 1.588
Nyköping 1.468
Wilmington 1.416
Ann Arbor 1.341
Beijing 948
New York 737
Roxbury 665
Lawrence 661
Lauterbourg 648
Nanjing 615
Los Angeles 531
Dallas 453
Des Moines 418
Bari 415
Helsinki 400
Princeton 322
São Paulo 321
Ho Chi Minh City 304
Inglewood 276
Munich 265
Brooklyn 261
Council Bluffs 256
Santa Clara 227
San Diego 200
Buffalo 185
Boardman 169
Hanoi 165
Abidjan 164
London 159
Shenyang 158
Nanchang 154
Dearborn 149
Chicago 142
Hebei 137
Brussels 129
Frankfurt am Main 128
Jakarta 128
Falkenstein 126
Jiaxing 125
Rome 124
Tokyo 111
Dublin 106
Tianjin 106
Moscow 104
Johannesburg 103
Milan 97
Warsaw 96
Tashkent 92
Rio de Janeiro 91
Orem 90
Baghdad 85
Grafing 84
Belo Horizonte 82
Changsha 81
Toronto 80
Montreal 79
Dong Ket 77
Chennai 74
Pune 74
Washington 72
Denver 71
Marseille 71
Dhaka 70
Paris 70
Stockholm 67
Guangzhou 66
Nuremberg 62
Redwood City 61
Phoenix 58
Atlanta 57
Curitiba 57
Manchester 57
Mexico City 56
Turku 56
The Dalles 55
Amsterdam 54
Brasília 54
Boston 53
Columbus 52
Porto Alegre 52
San Francisco 50
Salvador 49
Amman 47
Guayaquil 46
Lahore 45
Campinas 44
Jinan 43
Poplar 43
Brno 42
Ankara 39
Totale 48.747
Nome #
Significato clinico dell’interleuchina-2 (IL-2) e del suo recettore solubile nelle gammapatie monoclonali e nella crioglobulinemia mista essenziale 395
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 292
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 243
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 243
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 236
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma 228
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 216
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 216
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 209
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 202
Isolation and characterization of neural stem cells from dystrophic mdx mouse 200
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 196
Le tecniche immunoenzimatiche in immunoistochimica. L’immunoperossidasi e l’immunofosfatasi alcalina 195
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 191
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 190
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 188
Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch 187
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 187
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 185
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 184
A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the matrigel assay in vitro 183
Role of HDL and uric acid in vascular damage in well-controlled 182
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 182
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 182
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 182
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 180
Identify multiple myeloma stem cells: Utopia? 180
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 180
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 178
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy 177
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 177
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 176
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 176
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 176
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case report 175
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 175
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 175
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 174
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 173
Microenvironment drug resistance in multiple myeloma: Emerging new players 171
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 171
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 170
Targeting B-cell non Hodgkin lymphoma: New and old tricks 168
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 168
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 167
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 167
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 166
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 166
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 165
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression 162
Neutropenia and G-CSF in lymphoproliferative diseases 162
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos 161
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 161
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 160
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 160
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients 159
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 159
Giant cell arteritis: The experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements 159
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 156
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 155
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 155
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 154
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 153
A favorable response to omalizumab in a patient with cheilitis granulomatosa 153
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 153
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma 151
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 151
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 151
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo 151
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 151
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 151
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 150
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 150
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 149
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 149
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 148
Cryptpogenic stroke: the complex interplay between endothelial dysfunction and interatrial defects orchestred by MTHFR mutation 148
Bortezomib treatment modulates autophagy in multiple myeloma 148
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 147
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 146
Targeting vasculogenesis to prevent progression in multiple myeloma 145
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 145
Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis 144
Angiogenesis and anti-angiogenesis in neuroblastoma 144
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 144
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 143
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 142
Acute intratoracic gastric volvulus from a diaphragmatic hernia after left splenopancreatectomy: report of a case 141
A case of Cogan's syndrome resolved with mycophenolate sodium 141
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 141
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 140
Pharmacological activation of protein phosphatase 2 A (PP2A): A novel strategy to fight against human malignancies? 140
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 140
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 140
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents 139
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 139
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 139
Potential Role of MTHFR mutation in the interdipendence between interatrial defects and thrombophilia 138
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 138
Flogosis and heart involvement in large vessel vasculitis 137
Totale 17.028
Categoria #
all - tutte 313.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 313.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.917 0 0 0 0 0 0 0 0 0 880 547 490
2021/20224.965 301 658 73 208 246 285 283 268 298 372 812 1.161
2022/20238.045 1.186 877 503 746 856 1.160 87 824 1.407 66 181 152
2023/20243.023 254 540 167 183 279 904 92 150 17 77 46 314
2024/202512.128 338 192 1.072 474 338 1.005 1.047 1.126 555 662 1.786 3.533
2025/202621.179 3.549 974 1.387 2.569 2.746 1.608 3.000 818 2.536 1.992 0 0
Totale 74.420